Table 2. The serum redox parameters of YD on atherosclerotic rats.
| Group | Dosage (g/kg) | SOD (KU/mL) | MDA (mmol/L) | GSH (mmol/L) | GSH-px (μ mol/L) |
|---|---|---|---|---|---|
| con | — | 3.05 ± 0.12** | 2.65 ± 0.13** | 17.84 ± 2.11** | 320.9 ± 21.1** |
| AS | — | 2.16 ± 0.43 | 5.74 ± 0.22 | 12.69 ± 1.02 | 247.0 ± 33.4 |
| Ator | 0.01 | 2.52 ± 0.23** | 3.19 ± 0.16** | 18.91 ± 0.85** | 856.4 ± 19.5** |
| YD-2.0 | 2.0 | 2.69 ± 0.30** | 3.34 ± 0.20** | 19.64 ± 0.69** | 1153.9 ± 30.3** |
| YD-1.0 | 1.0 | 2.78 ± 0.49** | 3.64 ± 0.27** | 16.84 ± 0.48** | 956.8 ± 25.4** |
| YD-0.5 | 0.5 | 2.93 ± 0.42 | 4.07 ± 0.32** | 17.77 ± 1.03** | 860.3 ± 30.9** |
Number of experimental animals (N), total superoxide dismutase (T-SOD), glutathione peroxidase (GSH-PX), methane dicarboxylic aldehyd (MDA), reduced glutathione (GSH). Yindanxinnaotong (YD), atorvastatin (Ator).
Results are expressed as mean ± SD, n = 12.
*p < 0.05 vs the atherosclerosis model group, **p < 0.01 vs the athererosclersis model group.